NCCN Announces Selected Projects to Study Neratinib in Collaboration with Puma Biotechnology, Inc. ...Middle East

PR Newswire - News
NCCN Announces Selected Projects to Study Neratinib in Collaboration with Puma Biotechnology, Inc.
PLYMOUTH MEETING, Pa., July 15, 2021 /PRNewswire/ -- The National Comprehensive Cancer Network® (NCCN®) Oncology Research Program (ORP) today announced three research projects that have been selected for funding to evaluate neratinib in various tumor types. Neratinib is a type of tyrosine...

Hence then, the article about nccn announces selected projects to study neratinib in collaboration with puma biotechnology inc was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( NCCN Announces Selected Projects to Study Neratinib in Collaboration with Puma Biotechnology, Inc. )

Apple Storegoogle play

Last updated :

Also on site :



Latest News